Found: 28
Select item for more details and to access through your institution.
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1177, doi. 10.1007/s00280-008-0889-1
- By:
- Publication type:
- Article
A phase I study of Triapine<sup>®</sup> in combination with doxorubicin in patients with advanced solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- Report
Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1171, doi. 10.1007/s00280-008-0867-7
- By:
- Publication type:
- Article
Isolated molecular relapse in FIP1L1-PDGFRα hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1161, doi. 10.1007/s00280-008-0858-8
- By:
- Publication type:
- Article
Dual targeting of EGFR and HER-2 in colon cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 973, doi. 10.1007/s00280-008-0820-9
- By:
- Publication type:
- Article
Lack of toxicity of a STAT3 decoy oligonucleotide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 983, doi. 10.1007/s00280-008-0823-6
- By:
- Publication type:
- Article
Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 997, doi. 10.1007/s00280-008-0830-7
- By:
- Publication type:
- Article
Studies of structure–activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1007, doi. 10.1007/s00280-008-0802-y
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1073, doi. 10.1007/s00280-008-0826-3
- By:
- Publication type:
- Article
Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1023, doi. 10.1007/s00280-008-0825-4
- By:
- Publication type:
- Article
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1035, doi. 10.1007/s00280-008-0828-1
- By:
- Publication type:
- Article
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1049, doi. 10.1007/s00280-008-0827-2
- By:
- Publication type:
- Article
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x
- By:
- Publication type:
- Article
Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1017, doi. 10.1007/s00280-008-0831-6
- By:
- Publication type:
- Article
Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1157, doi. 10.1007/s00280-008-0859-7
- By:
- Publication type:
- Article
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1097, doi. 10.1007/s00280-008-0835-2
- By:
- Publication type:
- Article
Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1131, doi. 10.1007/s00280-008-0832-5
- By:
- Publication type:
- Article
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1103, doi. 10.1007/s00280-008-0838-z
- By:
- Publication type:
- Article
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1083, doi. 10.1007/s00280-008-0818-3
- By:
- Publication type:
- Article
Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1121, doi. 10.1007/s00280-008-0843-2
- By:
- Publication type:
- Article
Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1091, doi. 10.1007/s00280-008-0837-0
- By:
- Publication type:
- Article
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1111, doi. 10.1007/s00280-008-0834-3
- By:
- Publication type:
- Article
Life-threatening toxicities in a patient with UGT1A1* 6/* 28 and SLCO1B1* 15/* 15 genotypes after irinotecan-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1165, doi. 10.1007/s00280-008-0864-x
- By:
- Publication type:
- Article
5-FU pretreatment potentiates cisplatin-induced apoptosis through up-regulation of thrombospondin-1 in head and neck squamous cell carcinomas.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1141, doi. 10.1007/s00280-008-0839-y
- By:
- Publication type:
- Article